Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Researchers from the People's Friendship University of Russia (RUDN University) have studied the mechanism of drug resistance for ovarian and breast cancer cells. They discovered that these cancer ...